Lixivaptan in a Single Subject With Intractable Pain Due to Polycystic Kidney Disease

Summary

Abdominal pain, sometimes severe, is a known symptom of polycystic kidney disease (PKD) related to the cystic expansion. This study will investigate whether the vasopressin V2 receptor antagonist lixivaptan can alleviate intractable pain in a pediatric PKD patient who cannot tolerate the related vasopressin V2 receptor antagonist tolvaptan.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications